Olanzapine treatment for tics in an adult woman with severe tourette syndrome

Acta Neurologica Taiwanica

Volumn 21, Issue 4, 2012, Pages 165-168

  Hwang, Wen Juh ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Adult woman; Olanzapine; Tourette syndrome

Indexed keywords

CLONAZEPAM; CLOZAPINE; OLANZAPINE; PERGOLIDE; QUETIAPINE; RISPERIDONE;

ADULT; AMENORRHEA; ARTICLE; CASE REPORT; DISEASE SEVERITY; DROWSINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG TOLERABILITY; EVENING DOSAGE; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; LONG TERM CARE; MENSTRUAL CYCLE; OUTCOME ASSESSMENT; PREGNANCY; PROLACTIN BLOOD LEVEL; RATING SCALE; SIDE EFFECT; TIC; TREATMENT RESPONSE; WEIGHT GAIN;

ADULT; BENZODIAZEPINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TICS; TOURETTE SYNDROME;

EID: 84873344059     PISSN: 1028768X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Shapiro E, Shapiro AK, Fulop G, Hubbard M, Mandeli J, Nordlie J, Phillips RA. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1989;46:722- 730. (Pubitemid 19198099)
2. Jiménez-Jiménez FJ, García-Ruiz PJ. Pharmacological options for the treatment of Tourette's disorder. Drugs 2001;61:2207-2220. (Pubitemid 34074802)
3. Fulton B, Goa KL. Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses. Drugs 1997; 53:281-298. (Pubitemid 27073117)
4. Van den Eynde F, Naudts KH, De Saedeleer S, van Heeringen C, Audenaert K. Olanzapine in Gilles de la Tourette syndrome: beyond tics. Acta Neurol Belg 2005; 105:206-211. (Pubitemid 43173722)
5. Karam-Hage M, Ghaziuddin N. Olanzapine in Tourette's disorder. J Am Acad Child Adolesc Psychiatry 2000;39: 139.
6. Bhadrinath BR. Olanzapine in Tourette syndrome. Br J Psychiatry 1998;172:366.
7. Bengi Semerci Z. Olanzapine in Tourette's disorder. J Am Acad Child Adolesc Psychiatry 2000;39:140.
8. McCracken JT, Suddath R, Chang S, Thakur S, Piacentini J. Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome. J Child Adolesc Psychopharmacol 2008;18:501-508.
9. Budman CL, Gayer A, Lesser M, Shi Q, Bruun RD. An open-label study of the treatment efficacy of olanzapine for Tourette's disorder. J Clin Psychiatry 2001;62:290-294. (Pubitemid 32428769)
10. Stamenkovic M, Schindler SD, Aschauer HN, de Zwaan M, Willinger U, Resinger E, Kasper S. Effective open-label treatment of Tourette's disorder with olanzapine. Int Clin Psychopharmacol 2000;15:23-28. (Pubitemid 30058135)
11. Stephens RJ, Bassel C, Sandor P. Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome- a pilot study. J Child Adolesc Psychopharmacol 2004;14:255-266. (Pubitemid 38988791)
12. Onofrj M, Paci C, D'Andreamatteo G, Toma L. Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double- blind cross-over study vs. low-dose pimozide. J Neurol 2000;247:443-446. (Pubitemid 30433558)
13. Goetz CG, Pappert EJ, Louis ED, Raman R, Leurgans S. Advantages of a modified scoring method for the Rush Video-Based Tic Rating Scale. Mov Disord 1999;14:502- 506. (Pubitemid 30011665)
14. Peterson BS. Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome. J Clin Psychiatry 1996;57:24-34. (Pubitemid 26327754)
15. Pappert EJ, Goetz CG, Louis ED, Blasucci L, Leurgans S. Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome. Neurology 2003;61:936-940. (Pubitemid 37248648)